The multifaceted roles of the invariant chain CD74 - More than just a chaperone

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1863, Issue 6, 2016, Pages 1269-1281

  Schröder, Bernd ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Antigen presentation; Cell migration; Endosomal trafficking; Intramembrane proteolysis; Invariant chain; Macrophage migration inhibitory factor

Indexed keywords

CD74 ANTIGEN; CHAPERONE; MACROPHAGE INFLAMMATORY PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; B LYMPHOCYTE ANTIGEN; HLA ANTIGEN CLASS 2; IMMUNOGLOBULIN RECEPTOR; INVARIANT CHAIN; MACROPHAGE MIGRATION INHIBITORY FACTOR RECEPTOR;

ANTIGEN PRESENTATION; CELL MIGRATION; CELL PROLIFERATION; DENDRITIC CELL; ENDOSOME; HUMAN; IMMUNOREGULATION; INTRACELLULAR TRANSPORT; KNOCKOUT MOUSE; MEMBRANE TRANSPORT; METASTASIS POTENTIAL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; REVIEW; TUMOR IMMUNITY; UPREGULATION; ANIMAL; BIOLOGICAL MODEL; IMMUNOLOGY; METABOLISM; METASTASIS; NEOPLASM; PATHOLOGY;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MODELS, IMMUNOLOGICAL; MOLECULAR CHAPERONES; NEOPLASM METASTASIS; NEOPLASMS; RECEPTORS, IMMUNOLOGIC; UP-REGULATION;

EID: 84962668562     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2016.03.026     Document Type: Review

References (146)

1. Jones P.P., Murphy D.B., Hewgill D., McDevitt H.O. Detection of a common polypeptide chain in I-A and I-E sub-region immunoprecipitates. Mol. Immunol. 1979, 16:51-60.
2. Long E.O., Strubin M., Wake C.T., Gross N., Carrel S., Goodfellow P., Accolla R.S., Mach B. Isolation of cDNA clones for the p33 invariant chain associated with HLA-DR antigens. Proc. Natl. Acad. Sci. U. S. A. 1983, 80:5714-5718.
3. Claesson L., Larhammar D., Rask L., Peterson P.A. cDNA clone for the human invariant gamma chain of class II histocompatibility antigens and its implications for the protein structure. Proc. Natl. Acad. Sci. U. S. A. 1983, 80:7395-7399.
4. Shachar I., Elliott E.A., Chasnoff B., Grewal I.S., Flavell R.A. Reconstitution of invariant chain function in transgenic mice in vivo by individual p31 and p41 isoforms. Immunity 1995, 3:373-383.
5. O'Sullivan D.M., Noonan D., Quaranta V. Four Ia invariant chain forms derive from a single gene by alternate splicing and alternate initiation of transcription/translation. J. Exp. Med. 1987, 166:444-460.
6. Strubin M., Berte C., Mach B. Alternative splicing and alternative initiation of translation explain the four forms of the Ia antigen-associated invariant chain. EMBO J. 1986, 5:3483-3488.
7. Strubin M., Long E.O., Mach B. Two forms of the Ia antigen-associated invariant chain result from alternative initiations at two in-phase AUGs. Cell 1986, 47:619-625.
8. Sung E., Jones P.P. The invariant chain of murine Ia antigens: its glycosylation, abundance and subcellular localization. Mol. Immunol. 1981, 18:899-913.
9. Koch N. Posttranslational modifications of the Ia-associated invariant protein p41 after gene transfer. Biochemistry 1988, 27:4097-4102.
10. Machamer C.E., Cresswell P. Biosynthesis and glycosylation of the invariant chain associated with HLA-DR antigens. J. Immunol. 1982, 129:2564-2569.
11. Miller J., Hatch J.A., Simonis S., Cullen S.E. Identification of the glycosaminoglycan-attachment site of mouse invariant-chain proteoglycan core protein by site-directed mutagenesis. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:1359-1363.
12. Simonis S., Cullen S.E. Fatty acylation of murine Ia alpha, beta, and invariant chains. J. Immunol. 1986, 136:2962-2967.
13. Koch N., Hammerling G.J. The HLA-D-associated invariant chain binds palmitic acid at the cysteine adjacent to the membrane segment. J. Biol. Chem. 1986, 261:3434-3440.
14. Hüttl S., Helfrich F., Mentrup T., Held S., Fukumori A., Steiner H., Saftig P., Fluhrer R., Schröder B. Substrate determinants of Signal peptide peptidase-like 2a (SPPL2a)-mediated Intramembrane Proteolysis of the Invariant chain CD74. Biochem. J. 2016, (in press). 10.1042/BCJ20160156.
15. Spiro R.C., Quaranta V. The invariant chain is a phosphorylated subunit of class II molecules. J. Immunol. 1989, 143:2589-2594.
16. Anderson H.A., Roche P.A. Phosphorylation regulates the delivery of MHC class II invariant chain complexes to antigen processing compartments. J. Immunol. 1998, 160:4850-4858.
17. Anderson H.A., Bergstralh D.T., Kawamura T., Blauvelt A., Roche P.A. Phosphorylation of the invariant chain by protein kinase C regulates MHC class II trafficking to antigen-processing compartments. J. Immunol. 1999, 163:5435-5443.
18. Kuwana T., Peterson P.A., Karlsson L. Exit of major histocompatibility complex class II-invariant chain p35 complexes from the endoplasmic reticulum is modulated by phosphorylation. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:1056-1061.
19. Trost M., English L., Lemieux S., Courcelles M., Desjardins M., Thibault P. The phagosomal proteome in interferon-gamma-activated macrophages. Immunity 2009, 30:143-154.
20. Marks M.S., Blum J.S., Cresswell P. Invariant chain trimers are sequestered in the rough endoplasmic reticulum in the absence of association with HLA class II antigens. J. Cell Biol. 1990, 111:839-855.
21. Roche P.A., Marks M.S., Cresswell P. Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain. Nature 1991, 354:392-394.
22. Bijlmakers M.J., Benaroch P., Ploegh H.L. Mapping functional regions in the lumenal domain of the class II-associated invariant chain. J. Exp. Med. 1994, 180:623-629.
23. Gedde-Dahl M., Freisewinkel I., Staschewski M., Schenck K., Koch N., Bakke O. Exon 6 is essential for invariant chain trimerization and induction of large endosomal structures. J. Biol. Chem. 1997, 272:8281-8287.
24. Ashman J.B., Miller J. A role for the transmembrane domain in the trimerization of the MHC class II-associated invariant chain. J. Immunol. 1999, 163:2704-2712.
25. Stockinger B., Pessara U., Lin R.H., Habicht J., Grez M., Koch N. A role of Ia-associated invariant chains in antigen processing and presentation. Cell 1989, 56:683-689.
26. Momburg F., Koch N., Moller P., Moldenhauer G., Butcher G.W., Hammerling G.J. Differential expression of Ia and Ia-associated invariant chain in mouse tissues after in vivo treatment with IFN-gamma. J. Immunol. 1986, 136:940-948.
27. Collins T., Korman A.J., Wake C.T., Boss J.M., Kappes D.J., Fiers W., Ault K.A., Gimbrone M.A., Strominger J.L., Pober J.S. Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 1984, 81:4917-4921.
28. Volc-Platzer B., Majdic O., Knapp W., Wolff K., Hinterberger W., Lechner K., Stingl G. Evidence of HLA-DR antigen biosynthesis by human keratinocytes in disease. J. Exp. Med. 1984, 159:1784-1789.
29. Basha G., Omilusik K., Chavez-Steenbock A., Reinicke A.T., Lack N., Choi K.B., Jefferies W.A. A CD74-dependent MHC class I endolysosomal cross-presentation pathway. Nat. Immunol. 2012, 13:237-245.
30. Koch N., McLellan A.D., Neumann J. A revised model for invariant chain-mediated assembly of MHC class II peptide receptors. Trends Biochem. Sci. 2007, 32:532-537.
31. Castellino F., Han R., Germain R.N. The transmembrane segment of invariant chain mediates binding to MHC class II molecules in a CLIP-independent manner. Eur. J. Immunol. 2001, 31:841-850.
32. Anderson M.S., Miller J. Invariant chain can function as a chaperone protein for class II major histocompatibility complex molecules. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:2282-2286.
33. Elliott E.A., Drake J.R., Amigorena S., Elsemore J., Webster P., Mellman I., Flavell R.A. The invariant chain is required for intracellular transport and function of major histocompatibility complex class II molecules. J. Exp. Med. 1994, 179:681-694.
34. Bikoff E.K., Huang L.Y., Episkopou V., van Meerwijk J., Germain R.N., Robertson E.J. Defective major histocompatibility complex class II assembly, transport, peptide acquisition, and CD4+ T cell selection in mice lacking invariant chain expression. J. Exp. Med. 1993, 177:1699-1712.
35. Bikoff E.K., Germain R.N., Robertson E.J. Allelic differences affecting invariant chain dependency of MHC class II subunit assembly. Immunity 1995, 2:301-310.
36. Khalil H., Brunet A., Thibodeau J. A three-amino-acid-long HLA-DRbeta cytoplasmic tail is sufficient to overcome ER retention of invariant-chain p35. J. Cell Sci. 2005, 118:4679-4687.
37. Nordeng T.W., Gregers T.F., Kongsvik T.L., Meresse S., Gorvel J.P., Jourdan F., Motta A., Bakke O. The cytoplasmic tail of invariant chain regulates endosome fusion and morphology. Mol. Biol. Cell 2002, 13:1846-1856.
38. Bikoff E.K., Kenty G., Van K.L. Distinct peptide loading pathways for MHC class II molecules associated with alternative Ii chain isoforms. J. Immunol. 1998, 160:3101-3110.
39. Geneve L., Chemali M., Desjardins M., Labrecque N., Thibodeau J. Human invariant chain isoform p35 restores thymic selection and antigen presentation in CD74-deficient mice. Immunol. Cell Biol. 2012, 90:896-902.
40. Fortin J.S., Cloutier M., Thibodeau J. Exposing the specific roles of the invariant chain isoforms in shaping the MHC class II peptidome. Front. Immunol. 2013, 4:443.
41. Bakke O., Dobberstein B. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell 1990, 63:707-716.
42. Bremnes B., Madsen T., Gedde-Dahl M., Bakke O. An LI and ML motif in the cytoplasmic tail of the MHC-associated invariant chain mediate rapid internalization. J. Cell Sci. 1994, 107(Pt 7):2021-2032.
43. Odorizzi C.G., Trowbridge I.S., Xue L., Hopkins C.R., Davis C.D., Collawn J.F. Sorting signals in the MHC class II invariant chain cytoplasmic tail and transmembrane region determine trafficking to an endocytic processing compartment. J. Cell Biol. 1994, 126:317-330.
44. Pieters J., Bakke O., Dobberstein B. The MHC class II-associated invariant chain contains two endosomal targeting signals within its cytoplasmic tail. J. Cell Sci. 1993, 106(Pt 3):831-846.
45. Bonifacino J.S., Traub L.M. Signals for sorting of transmembrane proteins to endosomes and lysosomes. Annu. Rev. Biochem. 2003, 72:395-447.
46. Pieters J., Horstmann H., Bakke O., Griffiths G., Lipp J. Intracellular transport and localization of major histocompatibility complex class II molecules and associated invariant chain. J. Cell Biol. 1991, 115:1213-1223.
47. Joffre O.P., Segura E., Savina A., Amigorena S. Cross-presentation by dendritic cells. Nat. Rev. Immunol. 2012, 12:557-569.
48. Guncar G., Pungercic G., Klemencic I., Turk V., Turk D. Crystal structure of MHC class II-associated p41 Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S. EMBO J. 1999, 18:793-803.
49. Lennon-Dumenil A.M., Roberts R.A., Valentijn K., Driessen C., Overkleeft H.S., Erickson A., Peters P.J., Bikoff E., Ploegh H.L., Wolf B.P. The p41 isoform of invariant chain is a chaperone for cathepsin L. EMBO J. 2001, 20:4055-4064.
50. Fiebiger E., Maehr R., Villadangos J., Weber E., Erickson A., Bikoff E., Ploegh H.L., Lennon-Dumenil A.M. Invariant chain controls the activity of extracellular cathepsin L. J. Exp. Med. 2002, 196:1263-1269.
51. Mihelic M., Dobersek A., Guncar G., Turk D. Inhibitory fragment from the p41 form of invariant chain can regulate activity of cysteine cathepsins in antigen presentation. J. Biol. Chem. 2008, 283:14453-14460.
52. Landsverk O.J., Bakke O., Gregers T.F. MHC II and the endocytic pathway: regulation by invariant chain. Scand. J. Immunol. 2009, 70:184-193.
53. Viville S., Neefjes J., Lotteau V., Dierich A., Lemeur M., Ploegh H., Benoist C., Mathis D. Mice lacking the MHC class II-associated invariant chain. Cell 1993, 72:635-648.
54. Shachar I., Flavell R.A. Requirement for invariant chain in B cell maturation and function. Science 1996, 274:106-108.
55. Matza D., Lantner F., Bogoch Y., Flaishon L., Hershkoviz R., Shachar I. Invariant chain induces B cell maturation in a process that is independent of its chaperonic activity. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:3018-3023.
56. Maehr R., Kraus M., Ploegh H.L. Mice deficient in invariant-chain and MHC class II exhibit a normal mature B2 cell compartment. Eur. J. Immunol. 2004, 34:2230-2236.
57. Schneppenheim J., Dressel R., Hüttl S., Lüllmann-Rauch R., Engelke M., Dittmann K., Wienands J., Eskelinen E.L., Hermans-Borgmeyer I., Fluhrer R., Saftig P., Schröder B. The intramembrane protease SPPL2a promotes B cell development and controls endosomal traffic by cleavage of the invariant chain. J. Exp. Med. 2013, 210:41-58.
58. Madsen L., Labrecque N., Engberg J., Dierich A., Svejgaard A., Benoist C., Mathis D., Fugger L. Mice lacking all conventional MHC class II genes. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:10338-10343.
59. Koonce C.H., Bikoff E.K. Dissecting MHC class II export, B cell maturation, and DM stability defects in invariant chain mutant mice. J. Immunol. 2004, 173:3271-3280.
60. Labrecque N., Madsen L., Fugger L., Benoist C., Mathis D. Toxic MHC class II beta chains. Immunity 1999, 11:515-516.
61. Matza D., Kerem A., Medvedovsky H., Lantner F., Shachar I. Invariant chain-induced B cell differentiation requires intramembrane proteolytic release of the cytosolic domain. Immunity 2002, 17:549-560.
62. Nakagawa T.Y., Rudensky A.Y. The role of lysosomal proteinases in MHC class II-mediated antigen processing and presentation. Immunol. Rev. 1999, 172:121-129.
63. Driessen C., Bryant R.A., Lennon-Dumenil A.M., Villadangos J.A., Bryant P.W., Shi G.P., Chapman H.A., Ploegh H.L. Cathepsin S controls the trafficking and maturation of MHC class II molecules in dendritic cells. J. Cell Biol. 1999, 147:775-790.
64. Beers C., Burich A., Kleijmeer M.J., Griffith J.M., Wong P., Rudensky A.Y. Cathepsin S controls MHC class II-mediated antigen presentation by epithelial cells in vivo. J. Immunol. 2005, 174:1205-1212.
65. Nakagawa T., Roth W., Wong P., Nelson A., Farr A., Deussing J., Villadangos J.A., Ploegh H., Peters C., Rudensky A.Y. Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science 1998, 280:450-453.
66. Shi G.P., Bryant R.A., Riese R., Verhelst S., Driessen C., Li Z., Bromme D., Ploegh H.L., Chapman H.A. Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages. J. Exp. Med. 2000, 191:1177-1186.
67. Fineschi B., Arneson L.S., Naujokas M.F., Miller J. Proteolysis of major histocompatibility complex class II-associated invariant chain is regulated by the alternatively spliced gene product, p41. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:10257-10261.
68. Pierre P., Mellman I. Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell 1998, 93:1135-1145.
69. Magister S., Obermajer N., Mirkovic B., Svajger U., Renko M., Softic A., Romih R., Colbert J.D., Watts C., Kos J. Regulation of cathepsins S and L by cystatin F during maturation of dendritic cells. Eur. J. Cell Biol. 2012, 91:391-401.
70. El-Sukkari D., Wilson N.S., Hakansson K., Steptoe R.J., Grubb A., Shortman K., Villadangos J.A. The protease inhibitor cystatin C is differentially expressed among dendritic cell populations, but does not control antigen presentation. J. Immunol. 2003, 171:5003-5011.
71. Becker-Herman S., Arie G., Medvedovsky H., Kerem A., Shachar I. CD74 is a member of the regulated intramembrane proteolysis-processed protein family. Mol. Biol. Cell 2005, 16:5061-5069.
72. Beisner D.R., Langerak P., Parker A.E., Dahlberg C., Otero F.J., Sutton S.E., Poirot L., Barnes W., Young M.A., Niessen S., Wiltshire T., Bodendorf U., Martoglio B., Cravatt B., Cooke M.P. The intramembrane protease Sppl2a is required for B cell and DC development and survival via cleavage of the invariant chain. J. Exp. Med. 2013, 210:23-30.
73. Bergmann H., Yabas M., Short A., Miosge L., Barthel N., Teh C.E., Roots C.M., Bull K.R., Jeelall Y., Horikawa K., Whittle B., Balakishnan B., Sjollema G., Bertram E.M., MacKay F., Rimmer A.J., Cornall R.J., Field M.A., Andrews T.D., Goodnow C.C., Enders A. B cell survival, surface BCR and BAFFR expression, CD74 metabolism, and CD8-dendritic cells require the intramembrane endopeptidase SPPL2A. J. Exp. Med. 2013, 210:31-40.
74. Wolfe M.S. Intramembrane proteolysis. Chem. Rev. 2009, 109:1599-1612.
75. Annaert W.G., Saftig P. Regulated intramembrane proteolysis-a story about sheddases and I-CliPs. Semin. Cell Dev. Biol. 2009, 20:125.
76. Voss M., Schröder B., Fluhrer R. Mechanism, specificity, and physiology of signal peptide peptidase (SPP) and SPP-like proteases. Biochim. Biophys. Acta 2013, 1828:2828-2839.
77. Behnke J., Schneppenheim J., Koch-Nolte F., Haag F., Saftig P., Schröder B. Signal-peptide-peptidase-like 2a (SPPL2a) is targeted to lysosomes/late endosomes by a tyrosine motif in its C-terminal tail. FEBS Lett. 2011, 585:2951-2957.
78. Schneppenheim J., Hüttl S., Mentrup T., Lüllmann-Rauch R., Rothaug M., Engelke M., Dittmann K., Dressel R., Araki M., Araki K., Wienands J., Fluhrer R., Saftig P., Schröder B. The intramembrane proteases signal Peptide peptidase-like 2a and 2b have distinct functions in vivo. Mol. Cell. Biol. 2014, 34:1398-1411.
79. Mentrup T., Hasler R., Fluhrer R., Saftig P., Schröder B. A cell-based assay reveals nuclear translocation of intracellular domains released by SPPL proteases. Traffic 2015, 16:871-892.
80. Matza D., Wolstein O., Dikstein R., Shachar I. Invariant chain induces B cell maturation by activating a TAF(II)105-NF-kappaB-dependent transcription program. J. Biol. Chem. 2001, 276:27203-27206.
81. Starlets D., Gore Y., Binsky I., Haran M., Harpaz N., Shvidel L., Becker-Herman S., Berrebi A., Shachar I. Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival. Blood 2006, 107:4807-4816.
82. Lantner F., Starlets D., Gore Y., Flaishon L., Yamit-Hezi A., Dikstein R., Leng L., Bucala R., Machluf Y., Oren M., Shachar I. CD74 induces TAp63 expression leading to B-cell survival. Blood 2007, 110:4303-4311.
83. Binsky I., Haran M., Starlets D., Gore Y., Lantner F., Harpaz N., Leng L., Goldenberg D.M., Shvidel L., Berrebi A., Bucala R., Shachar I. IL-8 secreted in a macrophage migration-inhibitory factor- and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:13408-13413.
84. Mii Y., Taira M. Secreted Wnt "inhibitors" are not just inhibitors: regulation of extracellular Wnt by secreted Frizzled-related proteins. Develop. Growth Differ. 2011, 53:911-923.
85. Esteve P., Bovolenta P. The advantages and disadvantages of sfrp1 and sfrp2 expression in pathological events. Tohoku J. Exp. Med. 2010, 221:11-17.
86. McLane L.M., Corbett A.H. Nuclear localization signals and human disease. IUBMB Life 2009, 61:697-706.
87. Schneppenheim J., Hüttl S., Kruchen A., Fluhrer R., Muller I., Saftig P., Schneppenheim R., Martin C.L., Schröder B. Signal-peptide-peptidase-like 2a is required for CD74 intramembrane proteolysis in human B cells. Biochem. Biophys. Res. Commun. 2014, 451:48-53.
88. Kurosaki T., Shinohara H., Baba Y. B cell signaling and fate decision. Annu. Rev. Immunol. 2010, 28:21-55.
89. Srinivasan L., Sasaki Y., Calado D.P., Zhang B., Paik J.H., Depinho R.A., Kutok J.L., Kearney J.F., Otipoby K.L., Rajewsky K. PI3 kinase signals BCR-dependent mature B cell survival. Cell 2009, 139:573-586.
90. Hüttl S., Kläsener K., Schweizer M., Schneppenheim J., Oberg H.H., Kabelitz D., Reth M., Saftig P., Schröder B. Processing of CD74 by the intramembrane protease SPPL2a is critical for B cell receptor signaling in transitional B cells. J. Immunol. 2015, 195:1548-1563.
91. Tzivion G., Dobson M., Ramakrishnan G. FoxO transcription factors; regulation by AKT and 14-3-3 proteins. Biochim. Biophys. Acta 2011, 1813:1938-1945.
92. Eijkelenboom A., Burgering B.M. FOXOs: signalling integrators for homeostasis maintenance. Nat. Rev. Mol. Cell Biol. 2013, 14:83-97.
93. Zhang X., Tang N., Hadden T.J., Rishi A.K. Akt, FoxO and regulation of apoptosis. Biochim. Biophys. Acta 2011, 1813:1978-1986.
94. Romagnoli P., Layet C., Yewdell J., Bakke O., Germain R.N. Relationship between invariant chain expression and major histocompatibility complex class II transport into early and late endocytic compartments. J. Exp. Med. 1993, 177:583-596.
95. Gorvel J.P., Escola J.M., Stang E., Bakke O. Invariant chain induces a delayed transport from early to late endosomes. J. Biol. Chem. 1995, 270:2741-2746.
96. Gregers T.F., Nordeng T.W., Birkeland H.C., Sandlie I., Bakke O. The cytoplasmic tail of invariant chain modulates antigen processing and presentation. Eur. J. Immunol. 2003, 33:277-286.
97. Landsverk O.J., Barois N., Gregers T.F., Bakke O. Invariant chain increases the half-life of MHC II by delaying endosomal maturation. Immunol. Cell Biol. 2011, 89:619-629.
98. Boes M., van der Wel N., Peperzak V., Kim Y.M., Peters P.J., Ploegh H. In vivo control of endosomal architecture by class II-associated invariant chain and cathepsin S. Eur. J. Immunol. 2005, 35:2552-2562.
99. Lagaudriere-Gesbert C., Newmyer S.L., Gregers T.F., Bakke O., Ploegh H.L. Uncoating ATPase Hsc70 is recruited by invariant chain and controls the size of endocytic compartments. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:1515-1520.
100. Vascotto F., Lankar D., Faure-Andre G., Vargas P., Diaz J., Le Roux D., Yuseff M.I., Sibarita J.B., Boes M., Raposo G., Mougneau E., Glaichenhaus N., Bonnerot C., Manoury B., Lennon-Dumenil A.M. The actin-based motor protein myosin II regulates MHC class II trafficking and BCR-driven antigen presentation. J. Cell Biol. 2007, 176:1007-1019.
101. Heuze M.L., Vargas P., Chabaud M., Le B.M., Liu Y.J., Collin O., Solanes P., Voituriez R., Piel M., Lennon-Dumenil A.M. Migration of dendritic cells: physical principles, molecular mechanisms, and functional implications. Immunol. Rev. 2013, 256:240-254.
102. Faure-Andre G., Vargas P., Yuseff M.I., Heuze M., Diaz J., Lankar D., Steri V., Manry J., Hugues S., Vascotto F., Boulanger J., Raposo G., Bono M.R., Rosemblatt M., Piel M., Lennon-Dumenil A.M. Regulation of dendritic cell migration by CD74, the MHC class II-associated invariant chain. Science 2008, 322:1705-1710.
103. Chabaud M., Heuze M.L., Bretou M., Vargas P., Maiuri P., Solanes P., Maurin M., Terriac E., Le B.M., Lankar D., Piolot T., Adelstein R.S., Zhang Y., Sixt M., Jacobelli J., Benichou O., Voituriez R., Piel M., Lennon-Dumenil A.M. Cell migration and antigen capture are antagonistic processes coupled by myosin II in dendritic cells. Nat. Commun. 2015, 6:7526.
104. Calandra T., Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat. Rev. Immunol. 2003, 3:791-800.
105. Calandra T., Echtenacher B., Roy D.L., Pugin J., Metz C.N., Hultner L., Heumann D., Mannel D., Bucala R., Glauser M.P. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat. Med. 2000, 6:164-170.
106. Merk M., Mitchell R.A., Endres S., Bucala R. D-dopachrome tautomerase (D-DT or MIF-2): doubling the MIF cytokine family. Cytokine 2012, 59:10-17.
107. Roger T., David J., Glauser M.P., Calandra T. MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 2001, 414:920-924.
108. Gore Y., Starlets D., Maharshak N., Becker-Herman S., Kaneyuki U., Leng L., Bucala R., Shachar I. Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex. J. Biol. Chem. 2008, 283:2784-2792.
109. Sapoznikov A., Pewzner-Jung Y., Kalchenko V., Krauthgamer R., Shachar I., Jung S. Perivascular clusters of dendritic cells provide critical survival signals to B cells in bone marrow niches. Nat. Immunol. 2008, 9:388-395.
110. Koch N., Koch S., Hammerling G.J. Ia invariant chain detected on lymphocyte surfaces by monoclonal antibody. Nature 1982, 299:644-645.
111. Leng L., Metz C.N., Fang Y., Xu J., Donnelly S., Baugh J., Delohery T., Chen Y., Mitchell R.A., Bucala R. MIF signal transduction initiated by binding to CD74. J. Exp. Med. 2003, 197:1467-1476.
112. Shi X., Leng L., Wang T., Wang W., Du X., Li J., McDonald C., Chen Z., Murphy J.W., Lolis E., Noble P., Knudson W., Bucala R. CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 2006, 25:595-606.
113. Schwartz V., Lue H., Kraemer S., Korbiel J., Krohn R., Ohl K., Bucala R., Weber C., Bernhagen J. A functional heteromeric MIF receptor formed by CD74 and CXCR4. FEBS Lett. 2009, 583:2749-2757.
114. Lue H., Kapurniotu A., Fingerle-Rowson G., Roger T., Leng L., Thiele M., Calandra T., Bucala R., Bernhagen J. Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity. Cell. Signal. 2006, 18:688-703.
115. Lue H., Thiele M., Franz J., Dahl E., Speckgens S., Leng L., Fingerle-Rowson G., Bucala R., Luscher B., Bernhagen J. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity. Oncogene 2007, 26:5046-5059.
116. Mitchell R.A., Liao H., Chesney J., Fingerle-Rowson G., Baugh J., David J., Bucala R. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:345-350.
117. Stoppe C., Rex S., Goetzenich A., Kraemer S., Emontzpohl C., Soppert J., Averdunk L., Sun Y., Rossaint R., Lue H., Huang C., Song Y., Pantouris G., Lolis E., Leng L., Schulte W., Bucala R., Weber C., Bernhagen J. Interaction of MIF family proteins in myocardial ischemia/reperfusion damage and their influence on clinical outcome of cardiac surgery patients. Antioxid. Redox Signal. 2015, 23:865-879.
118. Assis D.N., Leng L., Du X., Zhang C.K., Grieb G., Merk M., Garcia A.B., McCrann C., Chapiro J., Meinhardt A., Mizue Y., Nikolic-Paterson D.J., Bernhagen J., Kaplan M.M., Zhao H., Boyer J.L., Bucala R. The role of macrophage migration inhibitory factor in autoimmune liver disease. Hepatology 2014, 59:580-591.
119. Schwartz V., Kruttgen A., Weis J., Weber C., Ostendorf T., Lue H., Bernhagen J. Role for CD74 and CXCR4 in clathrin-dependent endocytosis of the cytokine MIF. Eur. J. Cell Biol. 2012, 91:435-449.
120. Burton J.D., Ely S., Reddy P.K., Stein R., Gold D.V., Cardillo T.M., Goldenberg D.M. CD74 is expressed by multiple myeloma and is a promising target for therapy. Clin. Cancer Res. 2004, 10:6606-6611.
121. Porter D., Lahti-Domenici J., Keshaviah A., Bae Y.K., Argani P., Marks J., Richardson A., Cooper A., Strausberg R., Riggins G.J., Schnitt S., Gabrielson E., Gelman R., Polyak K. Molecular markers in ductal carcinoma in situ of the breast. Mol. Cancer Res. 2003, 1:362-375.
122. Greenwood C., Metodieva G., Al-Janabi K., Lausen B., Alldridge L., Leng L., Bucala R., Fernandez N., Metodiev M.V. Stat1 and CD74 overexpression is co-dependent and linked to increased invasion and lymph node metastasis in triple-negative breast cancer. J. Proteome 2012, 75:3031-3040.
123. Tamori Y., Tan X., Nakagawa K., Takai E., Akagi J., Kageshita T., Egami H., Ogawa M. Clinical significance of MHC class II-associated invariant chain expression in human gastric carcinoma. Oncol. Rep. 2005, 14:873-877.
124. Gold D.V., Stein R., Burton J., Goldenberg D.M. Enhanced expression of CD74 in gastrointestinal cancers and benign tissues. Int. J. Clin. Exp. Pathol. 2010, 4:1-12.
125. Ishigami S., Natsugoe S., Tokuda K., Nakajo A., Iwashige H., Aridome K., Hokita S., Aikou T. Invariant chain expression in gastric cancer. Cancer Lett. 2001, 168:87-91.
126. Cuthbert R.J., Wilson J.M., Scott N., Coletta P.L., Hull M.A. Differential CD74 (major histocompatibility complex Class II invariant chain) expression in mouse and human intestinal adenomas. Eur. J. Cancer 2009, 45:1654-1663.
127. McClelland M., Zhao L., Carskadon S., Arenberg D. Expression of CD74, the receptor for macrophage migration inhibitory factor, in non-small cell lung cancer. Am. J. Pathol. 2009, 174:638-646.
128. Young A.N., Amin M.B., Moreno C.S., Lim S.D., Cohen C., Petros J.A., Marshall F.F., Neish A.S. Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers. Am. J. Pathol. 2001, 158:1639-1651.
129. Choi J.W., Kim Y., Lee J.H., Kim Y.S. CD74 expression is increased in high-grade, invasive urothelial carcinoma of the bladder. Int. J. Urol. 2012.
130. Meyer-Siegler K.L., Iczkowski K.A., Leng L., Bucala R., Vera P.L. Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells. J. Immunol. 2006, 177:8730-8739.
131. Koide N., Yamada T., Shibata R., Mori T., Fukuma M., Yamazaki K., Aiura K., Shimazu M., Hirohashi S., Nimura Y., Sakamoto M. Establishment of perineural invasion models and analysis of gene expression revealed an invariant chain (CD74) as a possible molecule involved in perineural invasion in pancreatic cancer. Clin. Cancer Res. 2006, 12:2419-2426.
132. Kitange G.J., Carlson B.L., Schroeder M.A., Decker P.A., Morlan B.W., Wu W., Ballman K.V., Giannini C., Sarkaria J.N. Expression of CD74 in high grade gliomas: a potential role in temozolomide resistance. J. Neuro-Oncol. 2010, 100:177-186.
133. Bach J.P., Deuster O., Balzer-Geldsetzer M., Meyer B., Dodel R., Bacher M. The role of macrophage inhibitory factor in tumorigenesis and central nervous system tumors. Cancer 2009, 115:2031-2040.
134. Liu Y.H., Lin C.Y., Lin W.C., Tang S.W., Lai M.K., Lin J.Y. Up-regulation of vascular endothelial growth factor-D expression in clear cell renal cell carcinoma by CD74: a critical role in cancer cell tumorigenesis. J. Immunol. 2008, 181:6584-6594.
135. Tomas A., Futter C.E., Eden E.R. EGF receptor trafficking: consequences for signaling and cancer. Trends Cell Biol. 2014, 24:26-34.
136. Stein R., Mattes M.J., Cardillo T.M., Hansen H.J., Chang C.H., Burton J., Govindan S., Goldenberg D.M. CD74: a new candidate target for the immunotherapy of B-cell neoplasms. Clin. Cancer Res. 2007, 13:5556s-5563s.
137. Kaufman J.L., Niesvizky R., Stadtmauer E.A., Chanan-Khan A., Siegel D., Horne H., Wegener W.A., Goldenberg D.M. Phase I, multicentre, dose-escalation trial of monotherapy with milatuzumab (humanized anti-CD74 monoclonal antibody) in relapsed or refractory multiple myeloma. Br. J. Haematol. 2013, 163:478-486.
138. Ye L., Liu X., Rout S.N., Li Z., Yan Y., Lu L., Kamala T., Nanda N.K., Song W., Samal S.K., Zhu X. The MHC class II-associated invariant chain interacts with the neonatal Fc gamma receptor and modulates its trafficking to endosomal/lysosomal compartments. J. Immunol. 2008, 181:2572-2585.
139. Zwart W., Peperzak V., de Vries E., Keller A.M., van der H.G., Veraar E.A., Geumann U., Janssen H., Janssen L., Naik S.H., Neefjes J., Borst J. The invariant chain transports TNF family member CD70 to MHC class II compartments in dendritic cells. J. Cell Sci. 2010, 123:3817-3827.
140. Xie L., Qiao X., Wu Y., Tang J. Beta-Arrestin1 mediates the endocytosis and functions of macrophage migration inhibitory factor. PLoS One 2011, 6:e16428.
141. Matsuda S., Matsuda Y., D'Adamio L. CD74 interacts with APP and suppresses the production of Abeta. Mol. Neurodegener. 2009, 4:41.
142. Szaszak M., Chen H.D., Chen H.C., Baukal A., Hunyady L., Catt K.J. Identification of the invariant chain (CD74) as an angiotensin AGTR1-interacting protein. J. Endocrinol. 2008, 199:165-176.
143. Zhou C., Lu L., Tan S., Jiang S., Chen Y.H. HIV-1 glycoprotein 41 ectodomain induces activation of the CD74 protein-mediated extracellular signal-regulated kinase/mitogen-activated protein kinase pathway to enhance viral infection. J. Biol. Chem. 2011, 286:44869-44877.
144. Hussain A., Wesley C., Khalid M., Chaudhry A., Jameel S. Human immunodeficiency virus type 1 Vpu protein interacts with CD74 and modulates major histocompatibility complex class II presentation. J. Virol. 2008, 82:893-902.
145. Pancio H.A., Vander H.N., Kosuri K., Cresswell P., Ratner L. Interaction of human immunodeficiency virus type 2 Vpx and invariant chain. J. Virol. 2000, 74:6168-6172.
146. Beswick E.J., Pinchuk I.V., Minch K., Suarez G., Sierra J.C., Yamaoka Y., Reyes V.E. The Helicobacter pylori urease B subunit binds to CD74 on gastric epithelial cells and induces NF-kappaB activation and interleukin-8 production. Infect. Immun. 2006, 74:1148-1155.